Keywords
birlamchi dismenoreya, differensial diagnostika,
endometriy
prostaglandin F2α
leykotrienlar,
How to Cite
Abstract
Ushbu ilmiy maqola mualliflarning avvalgi tadqiqotlarida aniqlangan o‘smir va yosh qizlar o‘rtasida birlamchi dismenoreyaning yuqori tarqalish darajasi (73.5%) hamda nazoratsiz dori qabul qilish muammolarining mantiqiy davomi hisoblanadi. Maqolada birlamchi dismenoreyaning chuqurlashtirilgan patofiziologik mexanizmlari (prostaglandinlar va leykotrienlar disbalansi), uni ikkilamchi dismenoreyadan (endometrioz, kistalar) farqlash variantlari va zamonaviy xalqaro ginekologik protokollarga asoslangan bosqichma-bosqich davolash algoritmlari keng yoritilgan.
Shuningdek, NYQV va gormonal terapiyaning maqsadli qo‘llanilishi, hayot tarzini
korreksiya qilish hamda asoratlarni erta oldini olish choralari ilmiy asoslab berilgan
References
1. Raximova, Z. R., & Ismailov, A. Z. (2026). Yosh qizlarda birlamchi dismenoreya muammosi va uning tibbiy-ijtimoiy jihatlari. Central Asian Medical University jurnali, 1-qism.
2. Berek, J. S. (2023). Berek & Novak's Gynecology (17th ed.). Lippincott Williams & Wilkins, pp. 410-418.
3. Proctor, M., & Farquhar, C. (2024). Diagnosis and management of dysmenorrhoea. British Medical Journal, 332(7550), 1134-1138.
4. Iacovides, S., Avidon, I., & Baker, F. C. (2025). What we know about primary dysmenorrhea today: A critical review. Human Reproduction Update, 21(6), 762- 778.
5. Ju, H., Jones, M., & Mishra, G. (2024). The prevalence and risk factors of dysmenorrhea. Epidemiologic Reviews, 36(1), 104-113.
This work is licensed under a Creative Commons Attribution 4.0 International License.
